Challenges posed by novel vaccines in a hyperlinked society both to doctors and the health of their patients

Alojz Ihan


Medicine in the developed world is becoming progressively more commercialized since patients (or, more accurately, medical consumers) are increasingly becoming the driving force of what we call medical progress. The doctors are primarily obliged to treat and help patients, but will always have also (commercial) temptation before him: to facilitate the consumer's desires and, with a warm heart, shoot to the far borders of medical knowledge and technology. A good example illustrating dilemma of beneficial vs commercial medicine are ethical challenges of some new vaccines developed recently. Since their earliest introduction in the late 18th century, vaccines have undoubtedly saved the lives of millions, while also fundamentally changing the way modern medicine is practiced. Many diseases that were once widespread are now eradicated, yet vaccine development faces ongoing challenges, including some important ethical considerations. Today there are over 300 vaccines in development and included in clinical trials. Among them, anti-addiction vaccines (Cocaine, Nicotine, Fentanyl, Heroin, Oxycodone) received a burst of media attention, because these vaccines could help people in recovery from addiction; however, many ethical and legal questions may arise before clinical use.


Conflicts of interest, physicians, commercialization, populism, public health, vaccine development, anti-addiction vaccines, vaccines for pregnant mothers, ethical and legal questions

Full Text:



Amirthalingam, G., Andrews, N., Campbell, H., Ribeiro, S., Kara, E., Donegan, K., et al. (2014) Effectiveness of maternal pertussis vaccination in England: an observational study, Lancet; 384(9953), pp. 1521-1528, doi: 10.1016/S0140-6736(14)60686-3.

Anderson, T. S., Dave, S., Good, C. B. & Gellad. W. F. (2014) Academic medical center leadership on pharmaceutical company boards of directors, JAMA, 311(13), pp. 1353–1355, doi: 10.1001/jama.2013.284925.

Baker, C. J. & Kasper, D. L. (1976) Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection, The New England Journal of Medicine, 294(14), pp. 753–756.

Bremer, P. T., Schlosburg, J. E., Banks, M. L., Steele, F. F., Zhou, B., Poklis, J. L. & Janda, K. D. (2017) Development of a clinically-viable heroin vaccine, Journal of the American Chemical Society, 139(25), pp. 8601–8611, doi: 10.1021/jacs.7b03334.

Berkowitz, B. & Spector, S. (1972) Evidence for active immunity to morphine in mice, Science, 178(4067), pp. 1290-1292, doi: 10.1126/science.178.4067.1290.

Bonese, K. F., Wainer, B. H., Fitch, F. W., Rothberg, R. M. & Schuster, C. R. (1974) Changes in heroin self-administration by a rhesus monkey after morphine immunization, Nature, 252, pp. 708-710, doi:10.1038/252708a0.

Beelera, J, A., Lambach, P., Fulton, T. R., Narayanan, D., Ortiz, J. R. & Omer, S. B. (2016) A systematic review of ethical issues in vaccine studies involving pregnant women, Human vaccines & immunotherapeutics, 12(8), pp. 1952–1959, doi: 10.1080/21645515.2016.1186312.

Carfora, A., Cassandro, P., Feola, A., La Sala, F., Petrella, R. & Borriello, R. (2018) Ethical Implications in Vaccine Pharmacotherapy for Treatment and Prevention of Drug of Abuse dependence, Journal of Bioethical Inqueries, 15(1), pp. 45-55, doi: 10.1007/s11673-017-9834-5.

Haney, M., Gunderson, E. W., Jiang, H., Collins, E. D. & Foltin, R. W. (2010) Cocainespecific antibodies blunt the subjective effects of smoked cocaine in humans, Biological Psychiatry, 67(1), pp. 59-65, doi: 10.1016/j.biopsych.2009.08.031.

Hawkins, B., Holden, C. & McCambridge, J. (2012) Alcohol industry influence on UK alcohol policy: a new research agenda for public health, Critical Public Health, 22(3), pp. 297–305, doi: 10.1080/09581596.2012.658027.

Leask, J. (2013) Pregnant women’s intention to take up a postpartum pertussis vaccine, and their willingness to take up the vaccine while pregnant: a cross sectional survey, Vaccine, 31(37), pp. 3972-3978, doi: 10.1016/j.vaccine.2013.06.015.

Lancefield, R. C. (1934) A Serological differentiation of specific types of bovine hemolytic streptococci (group B), Journal of Experimental Medicine, 59(4), pp. 441–458.

Nestle, M. (2016) Corporate funding of food and nutrition research: science or marketing? JAMA Internal Medicine, 76(1), pp. 13–14, doi: 10.1001/jamainternmed.2015.6667.

Osburn, A. (2008) Immunizing against Addiction: The Argument for Incorporating Emerging Anti-Addiction Vaccines into Existing Compulsory Immunization Statutes, Cleveland State Law Review, 56(159), pp. 174-185.

Perkmann, M., Tartari, V., McKelvey, M., Autio, E., Broström, A., D’Este, P., et al. (2013) Academic engagement and commercialisation: A review of the literature on university—industry relations, Research Policy, 42(2), pp. 423–442, doi: 10.1016/j.respol.2012.09.007

Polosa, R. & Benowitz, N. L. (2011) Treatment of nicotine addiction: present therapeutic options and pipeline developments, Trends in Pharmacological Sciences, 32(5), pp. 281-289, doi: 10.1016/

Regan, A. K., Mak, D. B., Hauck, Y. L., Gibbs, R., Tracey, L. & Effler, P. V. (2016) Trends in seasonal influenza vaccine uptake during pregnancy in Western Australia: implications for midwives, Women and Birth: journal of the Australian College of Midwives, 29(5), pp. 423-429. doi: 10.1016/j.wombi.2016.01.009.

Speed, E. & Mannion, R. (2017) The rise of post-truth populism in pluralist liberal democracies: challenges for health policy, International Journal of Health Policy and Management, 6(5), pp. 249–251, doi: 10.15171/IJHPM.2017.19

Stowe, G. N., Vendruscolo, L. F., Edwards, S., Schlosburg, J. E., Misra, K. K., Schulteis, G., Mayorov, A. V., Zakhari, J. S., Koob, G. F. & Janda, K. D. (2011) A Vaccine Strategy that Induces Protective Immunity against Heroin, Journal of Medicinal Chemistry, 54(14), pp. 5195-5204, doi: 10.1021/jm200461m.

Studdert, D. M., Mello, M. M. & Brennan, T. A. (2004) Financial Conflicts of Interest in Physicians' Relationships with the Pharmaceutical Industry—Self-Regulation in the Shadow of Federal Prosecution, The New England Journal of Medicine, 351(18), pp. 1891–1900, doi: 10.1056/NEJMlim042229.

Shen, X., Orson, F. M. & Kosten, T. R. (2011) Anti-addiction vaccines, F1000 Medicine Reports, (3), pp. 3-20, doi: 10.3410/M3-20

Volkow, N. D. & Collins, F. S. (2017) The role of science in addressing the opioid crisis, The New England Journal of Medicine, 377, pp. 391–394, doi: 10.1056/NEJMsr1706626.


  • There are currently no refbacks.